Effect of magnesium sulfate on extubation time and acute pain in coronary artery bypass surgery.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 19025526.
- Also identified by DOI 10.1111/j.1399-6576.2008.01783.x.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Post-operative pain control is one of the greatest concerns for both physicians and patients. In this study, the effect of magnesium sulfate (MgSO(4)) solution infusion on post-operative pain scores and extubation time in patients undergoing elective coronary artery bypass graft (CABG) surgeries was assessed. In a double-blind, randomized, placebo-controlled clinical trial, 218 patients scheduled for elective CABG were selected and randomly assigned to two groups. After matching inclusion and exclusion criteria for the patients, intravenous MgSO(4) was administered intraoperatively for one group and placebo to the second group. Except for this, all the cases were similar regarding anesthesia and surgery. The MgSO(4) patients were extubated sooner compared with the placebo group. Pain scores reported by the group who received MgSO(4) were less at the 6th, 12th, 18th and 24th hours after the operation; also, they needed less morphine sulfate during this period. The results demonstrated a significantly shortened post-operative time for extubation and reduced acute post-operative pain scores by intravenous MgSO(4) infusion during elective CABG surgery.
Medical subject headings
- Calcium Channel Blockers
- Coronary Artery Bypass
- Intubation, Intratracheal
- Magnesium Sulfate
- Postoperative Pain